Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Sunshine Guorun Pharmaceutical Research is a Chinese contract research organization (CRO) and a wholly-owned subsidiary of Beijing Sunshine Novo Pharmaceutical Research. The company specializes in providing integrated pharmaceutical R&D services, including drug discovery, chemical synthesis, formulation development, and bioanalytical services. It focuses on supporting the development of both innovative drugs and high-end generic medications across various therapeutic areas such as oncology and neurology. By leveraging the resources of its parent group, Sunshine Guorun offers end-to-end solutions that streamline the drug development process from preclinical research to regulatory approval.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Sunshine Guorun Pharmaceutical Research.